EV-102

N/A

Report date: 2022/05/10 11:43:12
NME

Base Information

Drug NameEV-102
Drug Alias NameEV102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor inverse agonistsSerotonin 5-HT1 receptors modulatorsCannabinoid CB2 receptor inverse agonists +[4] 
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptorTransient receptor potential channels +[4] 
Therapy Area/IndicationsRadiodermatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEnveric Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesEnveric Biosciences Inc
Inactive CompaniesN/A
Active IndicationsRadiodermatitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A